In a retrospective study of 85 patients with DLBCL, CD4+ T-cell counts decreased from baseline and were persistently low one year after CAR-T cell treatment, with a median CD4+ cell count of 155 cells/μL [147]. The gene discussed is CD4; the disease is diffuse large B-cell lymphoma.